首页 > 最新文献

Lancet Public Health最新文献

英文 中文
Hepatitis C: a continuing public health challenge in China 丙型肝炎:中国持续的公共卫生挑战
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-25 DOI: 10.1016/s2468-2667(25)00259-2
Rui Huang, Chao Wu
{"title":"Hepatitis C: a continuing public health challenge in China","authors":"Rui Huang, Chao Wu","doi":"10.1016/s2468-2667(25)00259-2","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00259-2","url":null,"abstract":"","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"30 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145592853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How lifestyle, social determinants of health, and sex shape life expectancy in China 生活方式、健康的社会决定因素和性别如何影响中国人的预期寿命
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-25 DOI: 10.1016/s2468-2667(25)00257-9
Yonghua Yu, Jieli Lu
{"title":"How lifestyle, social determinants of health, and sex shape life expectancy in China","authors":"Yonghua Yu, Jieli Lu","doi":"10.1016/s2468-2667(25)00257-9","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00257-9","url":null,"abstract":"","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"182 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145592857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
China's strategy for AI in public health 中国公共卫生领域人工智能战略
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-25 DOI: 10.1016/s2468-2667(25)00275-0
Siyan Zhan
{"title":"China's strategy for AI in public health","authors":"Siyan Zhan","doi":"10.1016/s2468-2667(25)00275-0","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00275-0","url":null,"abstract":"","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"20 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145592854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leveraging health taxation for public health gains in China 利用卫生税促进中国公共卫生收益
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-25 DOI: 10.1016/s2468-2667(25)00276-2
Shiwei Liu, Jing Wu
{"title":"Leveraging health taxation for public health gains in China","authors":"Shiwei Liu, Jing Wu","doi":"10.1016/s2468-2667(25)00276-2","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00276-2","url":null,"abstract":"","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"29 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145592855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opportunities to improve public health in China 改善中国公共卫生的机遇
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-24 DOI: 10.1016/s2468-2667(25)00280-4
On Oct 23, 2025, at the Central Committee of the Communist Party of China, the country's 15th 5-year plan, 2026–30, was announced. The final plan is to be unveiled in March 2026, but the recommendations clearly outline key goals for public health, including increasing life expectancy to 80 years, supporting reproductive health and health promotion, and ensuring equitable access to quality health care. Achieving these goals will require sustained effort, innovative strategies, and a strong commitment to addressing both existing and emerging public health challenges. This issue of The Lancet Public Health, our annual issue dedicated to health in China, highlights the progress made, the challenges ahead, and the opportunities to improve public health in the country.
2025年10月23日,中国共产党中央委员会宣布了中国第15个五年计划(2026 - 2030年)。最终计划将于2026年3月公布,但建议明确概述了公共卫生的关键目标,包括将预期寿命提高到80岁,支持生殖健康和促进健康,以及确保公平获得优质卫生保健。实现这些目标需要持续的努力、创新的战略以及对应对现有和新出现的公共卫生挑战的坚定承诺。这一期《柳叶刀公共卫生》是我们专门讨论中国卫生问题的年度刊物,重点介绍了中国在改善公共卫生方面取得的进展、面临的挑战和机遇。
{"title":"Opportunities to improve public health in China","authors":"","doi":"10.1016/s2468-2667(25)00280-4","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00280-4","url":null,"abstract":"On Oct 23, 2025, at the Central Committee of the Communist Party of China, the country's 15th 5-year plan, 2026–30, was announced. The final plan is to be unveiled in March 2026, but the recommendations clearly outline key goals for public health, including increasing life expectancy to 80 years, supporting reproductive health and health promotion, and ensuring equitable access to quality health care. Achieving these goals will require sustained effort, innovative strategies, and a strong commitment to addressing both existing and emerging public health challenges. This issue of <em>The Lancet Public Health</em>, our annual issue dedicated to health in China, highlights the progress made, the challenges ahead, and the opportunities to improve public health in the country.","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"14 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145594057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sleep health in China: status, challenges, and promotion strategies 中国的睡眠健康:现状、挑战与促进策略
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-09 DOI: 10.1016/s2468-2667(25)00250-6
Xiao-Xing Liu, Zhe Wang, Si-Jing Chen, Michael V Vitiello, Yun Kwok Wing, Charles M Morin, Jie Shi, Lin Lu
This Review synthesises the epidemiological patterns of sleep and sleep disturbance in China, discusses national strategies and challenges, and proposes future directions. To promote sleep health, the Chinese Government has implemented multifaceted strategies structured across three domains: national policies, health-care systems, and research systems. Despite these efforts, challenges persist in two areas: deep-seated factors that influence sleep disturbance, and systemic limitations in health care and surveillance that constrain an effective response. Progress will depend on a concerted strategy to transform socioeconomic and cultural norms, enhance public awareness, strengthen health-care systems, and build national research and technological infrastructure.
本文综述了中国睡眠和睡眠障碍的流行病学模式,讨论了国家的策略和挑战,并提出了未来的发展方向。为促进睡眠健康,中国政府实施了涉及三个领域的多方面战略:国家政策、卫生保健系统和研究系统。尽管做出了这些努力,但在两个领域仍然存在挑战:影响睡眠障碍的深层次因素,以及制约有效应对的卫生保健和监测方面的系统性限制。进展将取决于一项协调一致的战略,以改变社会经济和文化规范,提高公众意识,加强卫生保健系统,并建立国家研究和技术基础设施。
{"title":"Sleep health in China: status, challenges, and promotion strategies","authors":"Xiao-Xing Liu, Zhe Wang, Si-Jing Chen, Michael V Vitiello, Yun Kwok Wing, Charles M Morin, Jie Shi, Lin Lu","doi":"10.1016/s2468-2667(25)00250-6","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00250-6","url":null,"abstract":"This Review synthesises the epidemiological patterns of sleep and sleep disturbance in China, discusses national strategies and challenges, and proposes future directions. To promote sleep health, the Chinese Government has implemented multifaceted strategies structured across three domains: national policies, health-care systems, and research systems. Despite these efforts, challenges persist in two areas: deep-seated factors that influence sleep disturbance, and systemic limitations in health care and surveillance that constrain an effective response. Progress will depend on a concerted strategy to transform socioeconomic and cultural norms, enhance public awareness, strengthen health-care systems, and build national research and technological infrastructure.","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"19 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of healthy lifestyles and social determinants on independent life expectancy and sex differences in China: evidence from a 13-year cohort study 中国健康生活方式和社会决定因素对独立预期寿命和性别差异的影响:来自13年队列研究的证据
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-09 DOI: 10.1016/s2468-2667(25)00253-1
Longbing Ren, Ying Zhou, Keyang Liu, Hao Zhang, Shaojie Li, Yang Hu, Kokoro Shirai, Yuling Jiang, Yifei Wu, Mingzhi Yu, Jiakang Huo, Jie Li, Yan Zhang, Jing Sun, Bo Hu, Tai Hing Lam, David Bishai, Yi Zeng, Erdan Dong, Yao Yao
<h3>Background</h3>Functional independence is the basis for healthy ageing and quality of late life. However, evidence on how healthy lifestyle factors and social determinants of health affect longevity in independence remains limited, particularly regarding sex differences. We aimed to examine the associations of these factors with life expectancy with and without dependency, and to assess whether such effects differ by sex.<h3>Methods</h3>This cohort study used data from the nationally representative Chinese Longitudinal Healthy Longevity Study (CLHLS), which collected data from 2008 to 2021. Participants aged 65–100 years were included if they had at least one follow-up or death record. Healthy lifestyle factors (ie, diet, physical activity, smoking, and alcohol use) and social determinants of health (ie, financial status, education, health-care access, built environment, and social context) were assessed at baseline. Functional independence was determined by self-reported need for assistance with activities of daily living and instrumental activities of daily living at each survey wave. A continuous-time three-state Markov model was applied to estimate hazard ratios and 95% CIs between independence, dependence, and death, yielding total and independent life expectancy by sex, adjusted for covariates.<h3>Findings</h3>11 804 participants were included in the study. At age 65 years, females had longer total life expectancy than males (18·18 years [95% CI 17·74–18·49] <em>vs</em> 15·50 years [15·10–15·89]) but shorter independent life expectancy (10·35 years [10·13–10·55] <em>vs</em> 11·29 years [11·05–11·54]). The gain in independent life expectancy was greater for males with 3–4 healthy lifestyle factors versus males with 0–1 healthy lifestyle factors (2·45 years [2·24–2·67]) compared with females with 3–4 healthy lifestyle factors versus females with 0–1 healthy lifestyle factors (2·09 years [1·90–2·29], p=0·015). However, females had greater gains in independent life expectancy from favourable social determinants of health. Those with 4–5 positive social determinants of health indicators lived 1·95 (1·74–2·16) more years independently compared with those with 0–1, surpassing the 1·67 year (1·49–1·85) gain observed in males (p=0·047). The combination of both favourable lifestyle behaviours and supportive social conditions produced the largest improvement in independent life expectancy, with gains of 3·94 (3·73–4·15) years for males and 3·89 (3·68–4·11) years for females.<h3>Interpretation</h3>Pathways to healthy ageing differ between sexes in China: males benefit more from lifestyle modifications whereas females gain more from improved social conditions. These results underscore the importance of sex-specific public health strategies that focus on reducing unhealthy behaviours among males and improving social support for females.<h3>Funding</h3>National Natural Science Foundation of China and Chinese Academy of Medical Sciences Innovation Fund
功能独立是健康老龄化和高质量晚年生活的基础。然而,关于健康的生活方式因素和健康的社会决定因素如何影响独立寿命的证据仍然有限,特别是在性别差异方面。我们的目的是检查这些因素与预期寿命的关系,无论是否依赖,并评估这种影响是否因性别而异。方法本队列研究使用具有全国代表性的中国纵向健康寿命研究(CLHLS)的数据,该研究收集了2008年至2021年的数据。年龄在65-100岁之间的参与者,如果他们至少有一次随访或死亡记录。在基线时评估健康的生活方式因素(如饮食、体育活动、吸烟和饮酒)和健康的社会决定因素(如经济状况、教育、卫生保健获取、建筑环境和社会背景)。功能独立性是通过自我报告的日常生活活动和日常生活工具活动的帮助需求来确定的。应用连续时间三态马尔可夫模型估计独立、依赖和死亡之间的风险比和95% ci,得出按性别划分的总预期寿命和独立预期寿命,并对协变量进行调整。研究结果共有1804名参与者参与了这项研究。在65岁时,女性的总预期寿命比男性长(18.18岁[95% CI 17.74 - 18.49]比15.50岁[15.10 - 15.89]),但独立预期寿命比男性短(10.35岁[10.13 - 10.55]比11.29岁[11.05 - 11.54])。具有3-4种健康生活方式因素的男性比具有0 - 1种健康生活方式因素的男性(2.45岁[2.24 - 2.67])比具有3-4种健康生活方式因素的女性比具有0 - 1种健康生活方式因素的女性(2.09岁[1.90 - 2.29],p= 0.015)的独立预期寿命增加更大。然而,在健康的有利社会决定因素方面,女性的独立预期寿命获得了更大的增长。与健康指标为0 - 1的人相比,4-5个社会决定因素阳性的人独立多活1.95年(1.74 - 1.16)岁,超过男性的1.67年(1.49 - 1.85)年(p= 0.047)。良好的生活方式行为和支持性的社会条件相结合,对独立预期寿命的改善最大,男性增加了3.94(3.73 - 3.15)岁,女性增加了3.89(3.68 - 4.11)岁。在中国,健康老龄化的途径因性别而异:男性更多地受益于生活方式的改变,而女性则更多地受益于社会条件的改善。这些结果强调了针对不同性别的公共卫生战略的重要性,这些战略注重减少男性的不健康行为并改善对女性的社会支持。国家自然科学基金、中国医学科学院创新基金。摘要的中文译文见补充资料部分。
{"title":"The effect of healthy lifestyles and social determinants on independent life expectancy and sex differences in China: evidence from a 13-year cohort study","authors":"Longbing Ren, Ying Zhou, Keyang Liu, Hao Zhang, Shaojie Li, Yang Hu, Kokoro Shirai, Yuling Jiang, Yifei Wu, Mingzhi Yu, Jiakang Huo, Jie Li, Yan Zhang, Jing Sun, Bo Hu, Tai Hing Lam, David Bishai, Yi Zeng, Erdan Dong, Yao Yao","doi":"10.1016/s2468-2667(25)00253-1","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00253-1","url":null,"abstract":"&lt;h3&gt;Background&lt;/h3&gt;Functional independence is the basis for healthy ageing and quality of late life. However, evidence on how healthy lifestyle factors and social determinants of health affect longevity in independence remains limited, particularly regarding sex differences. We aimed to examine the associations of these factors with life expectancy with and without dependency, and to assess whether such effects differ by sex.&lt;h3&gt;Methods&lt;/h3&gt;This cohort study used data from the nationally representative Chinese Longitudinal Healthy Longevity Study (CLHLS), which collected data from 2008 to 2021. Participants aged 65–100 years were included if they had at least one follow-up or death record. Healthy lifestyle factors (ie, diet, physical activity, smoking, and alcohol use) and social determinants of health (ie, financial status, education, health-care access, built environment, and social context) were assessed at baseline. Functional independence was determined by self-reported need for assistance with activities of daily living and instrumental activities of daily living at each survey wave. A continuous-time three-state Markov model was applied to estimate hazard ratios and 95% CIs between independence, dependence, and death, yielding total and independent life expectancy by sex, adjusted for covariates.&lt;h3&gt;Findings&lt;/h3&gt;11 804 participants were included in the study. At age 65 years, females had longer total life expectancy than males (18·18 years [95% CI 17·74–18·49] &lt;em&gt;vs&lt;/em&gt; 15·50 years [15·10–15·89]) but shorter independent life expectancy (10·35 years [10·13–10·55] &lt;em&gt;vs&lt;/em&gt; 11·29 years [11·05–11·54]). The gain in independent life expectancy was greater for males with 3–4 healthy lifestyle factors versus males with 0–1 healthy lifestyle factors (2·45 years [2·24–2·67]) compared with females with 3–4 healthy lifestyle factors versus females with 0–1 healthy lifestyle factors (2·09 years [1·90–2·29], p=0·015). However, females had greater gains in independent life expectancy from favourable social determinants of health. Those with 4–5 positive social determinants of health indicators lived 1·95 (1·74–2·16) more years independently compared with those with 0–1, surpassing the 1·67 year (1·49–1·85) gain observed in males (p=0·047). The combination of both favourable lifestyle behaviours and supportive social conditions produced the largest improvement in independent life expectancy, with gains of 3·94 (3·73–4·15) years for males and 3·89 (3·68–4·11) years for females.&lt;h3&gt;Interpretation&lt;/h3&gt;Pathways to healthy ageing differ between sexes in China: males benefit more from lifestyle modifications whereas females gain more from improved social conditions. These results underscore the importance of sex-specific public health strategies that focus on reducing unhealthy behaviours among males and improving social support for females.&lt;h3&gt;Funding&lt;/h3&gt;National Natural Science Foundation of China and Chinese Academy of Medical Sciences Innovation Fund","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"79 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seroepidemiology of hepatitis C virus infection in people aged 1–69 years in China: a national, cross-sectional study 中国1-69岁人群丙型肝炎病毒感染的血清流行病学:一项全国性横断面研究
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-09 DOI: 10.1016/s2468-2667(25)00254-3
Jian Li, Lin Pang, Guowei Ding, Wenge Xing, Jiejun Yu, Hui Zheng, Yu Wang, Fuzhen Wang, Liping Shen, Jianhua Liu, Shaodong Ye, Lijian Pei, Feng Wang, Guomin Zhang, Ning Miao, Tongtong Meng, Zundong Yin, Jidong Jia, Jun Yan, Yu Wang, Zhongfu Liu

Background

China has a substantial disease burden of hepatitis C virus (HCV) infection. We aimed to analyse the findings from a national seroepidemiology survey of viral hepatitis in 2020, providing insights into the current state of hepatitis C in China.

Methods

A national, cross-sectional survey was conducted in China using a stratified, three-stage cluster random sampling method to select individuals aged 1–69 years from 160 national disease surveillance points. Venous blood samples that tested positive for anti-HCV antibodies were further tested for HCV RNA. Point estimates and 95% CIs of anti-HCV antibody and HCV RNA prevalence were calculated using Taylor series linearisation for variance estimations. The prevalence estimates were adjusted using weighted calculations. National HCV burden was estimated by the workbook method.

Findings

From Aug 1, 2020, to June 1, 2021, 91 971 individuals were surveyed in 120 counties, with 91 896 (99·9%) blood samples tested and included in the final analysis. The median age of participants was 33 years (IQR 15–52), 39 627 (43·1%) participants were male, 52 269 (56·9%) were female, 75 170 (81·8%) were of Han ethnicity, and 16 726 (18·2%) were in non-Han ethnic groups. 223 (0·24%) individuals tested positive for anti-HCV antibodies, with weighted prevalence of 0·28% (95% CI 0·24–0·34). Among these, 111 (49·8%) tested positive for HCV RNA, resulting in an HCV RNA positive proportion of 0·12% and weighted prevalence of 0·15% (95% CI 0·11–0·20). We estimated 5·54 million individuals who were anti-HCV antibody-positive and 3·22 million with viraemic infections.

Interpretation

The survey findings confirm that China has made important progress in controlling the hepatitis C epidemic. However, the absolute number of individuals infected with HCV remains substantial due to the large population denominator. Concerted efforts are essential to promote a comprehensive strategy to further curb the hepatitis C epidemic.

Funding

Major Science and Technology Special Project of China's 13th 5-Year Plan.

Translation

For the Chinese translation of the abstract see Supplementary Materials section.
背景:中国丙型肝炎病毒(HCV)感染的疾病负担很大。我们的目的是分析2020年全国病毒性肝炎血清流行病学调查的结果,为中国丙型肝炎的现状提供见解。方法采用分层三阶段整群随机抽样的方法,从中国160个国家疾病监测点中抽取年龄在1 ~ 69岁的个体进行全国性横断面调查。抗丙型肝炎病毒抗体检测呈阳性的静脉血样本进一步检测丙型肝炎病毒RNA。抗HCV抗体和HCV RNA患病率的点估计值和95% ci使用方差估计的泰勒序列线性化计算。使用加权计算调整患病率估计值。采用工作手册法估计全国丙型肝炎病毒负担。从2020年8月1日至2021年6月1日,在120个县共调查了91 971人,检测了91 896份(99.9%)血液样本并纳入最终分析。参与者年龄中位数为33岁(IQR 15-52),男性39 627人(43.1%),女性52 269人(56.9%),汉族75 170人(81.8%),非汉族16 726人(18.2%)。抗hcv抗体阳性223例(0.24%),加权患病率为0.28% (95% CI 0.24 - 0.34)。其中,HCV RNA阳性111例(49.8%),HCV RNA阳性比例为0.12%,加权患病率为0.15% (95% CI 0.11 - 0.20)。我们估计有554万人是抗hcv抗体阳性,322万人是病毒感染。调查结果证实,中国在控制丙型肝炎流行方面取得了重要进展。然而,由于人口基数大,感染丙型肝炎病毒的绝对人数仍然很大。协调一致的努力对于促进进一步遏制丙型肝炎流行的全面战略至关重要。国家“十三五”科技重大专项。摘要的中文译文见补充资料部分。
{"title":"Seroepidemiology of hepatitis C virus infection in people aged 1–69 years in China: a national, cross-sectional study","authors":"Jian Li, Lin Pang, Guowei Ding, Wenge Xing, Jiejun Yu, Hui Zheng, Yu Wang, Fuzhen Wang, Liping Shen, Jianhua Liu, Shaodong Ye, Lijian Pei, Feng Wang, Guomin Zhang, Ning Miao, Tongtong Meng, Zundong Yin, Jidong Jia, Jun Yan, Yu Wang, Zhongfu Liu","doi":"10.1016/s2468-2667(25)00254-3","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00254-3","url":null,"abstract":"<h3>Background</h3>China has a substantial disease burden of hepatitis C virus (HCV) infection. We aimed to analyse the findings from a national seroepidemiology survey of viral hepatitis in 2020, providing insights into the current state of hepatitis C in China.<h3>Methods</h3>A national, cross-sectional survey was conducted in China using a stratified, three-stage cluster random sampling method to select individuals aged 1–69 years from 160 national disease surveillance points. Venous blood samples that tested positive for anti-HCV antibodies were further tested for HCV RNA. Point estimates and 95% CIs of anti-HCV antibody and HCV RNA prevalence were calculated using Taylor series linearisation for variance estimations. The prevalence estimates were adjusted using weighted calculations. National HCV burden was estimated by the workbook method.<h3>Findings</h3>From Aug 1, 2020, to June 1, 2021, 91 971 individuals were surveyed in 120 counties, with 91 896 (99·9%) blood samples tested and included in the final analysis. The median age of participants was 33 years (IQR 15–52), 39 627 (43·1%) participants were male, 52 269 (56·9%) were female, 75 170 (81·8%) were of Han ethnicity, and 16 726 (18·2%) were in non-Han ethnic groups. 223 (0·24%) individuals tested positive for anti-HCV antibodies, with weighted prevalence of 0·28% (95% CI 0·24–0·34). Among these, 111 (49·8%) tested positive for HCV RNA, resulting in an HCV RNA positive proportion of 0·12% and weighted prevalence of 0·15% (95% CI 0·11–0·20). We estimated 5·54 million individuals who were anti-HCV antibody-positive and 3·22 million with viraemic infections.<h3>Interpretation</h3>The survey findings confirm that China has made important progress in controlling the hepatitis C epidemic. However, the absolute number of individuals infected with HCV remains substantial due to the large population denominator. Concerted efforts are essential to promote a comprehensive strategy to further curb the hepatitis C epidemic.<h3>Funding</h3>Major Science and Technology Special Project of China's 13th 5-Year Plan.<h3>Translation</h3>For the Chinese translation of the abstract see Supplementary Materials section.","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"114 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health and economic effects of increased taxation on tobacco, alcohol, and sugar-sweetened beverages in China: a modelling study 中国对烟草、酒精和含糖饮料增税对健康和经济的影响:一项模型研究
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-11-09 DOI: 10.1016/s2468-2667(25)00256-7
Tiange Chen, Jinyi Zhu, Sian Tsuei, Yunyun Jiang, Yunting Zheng, Duo Xu, Hongqiao Fu

Background

China faces substantial burdens from tobacco, alcohol, and sugar-sweetened beverage (SSB) consumption, yet tax increases on these products have been stagnant. Existing evidence on the health, economic, and fiscal effects of such taxes in China is limited, which hinders tax reforms on tobacco and alcohol and implementation of SSB excise taxes. We aim to quantify the potential effects of increasing these taxes in China.

Methods

We modelled the health, macroeconomic, and fiscal consequences under different tax increase scenarios in China between 2026 and 2050. Years of life gained (YLGs), deaths averted, and additional fiscal revenue were estimated using a cohort state-transition model incorporating age-specific, sex-specific, and income-specific demographic projections, consumption patterns, price elasticities, and relative risk estimates. Macroeconomic benefits were calculated through enhanced labour supply and reduced health-care expenditures using a health-augmented macroeconomic model. Sensitivity analyses were conducted to account for parameter and structural uncertainties.

Findings

From 2026 to 2050, under 20% price increases through tax hikes, taxation of tobacco, alcohol, and SSBs would generate 20·58 million (95% uncertainty interval 12·53–29·19), 9·02 million (5·61–12·92), and 3·67 million (2·40–5·05) YLGs, respectively, and avert 0·86 million (0·53–1·23), 0·36 million (0·22–0·51), and 0·13 million (0·09–0·19) deaths, respectively. Health benefits were concentrated among lower-income groups and males. These health improvements would translate into macroeconomic gains equivalent to 0·043% (0·031–0·060), 0·034% (0·024–0·047), and 0·0016% (0·0013–0·0019) of total gross domestic product, respectively. Additional fiscal revenues would total ¥4·53 trillion (3·70–5·50) for tobacco, ¥2·00 trillion (1·75–2·29) for alcohol, and ¥295·5 billion (227·9–377·1) for SSBs. Higher taxes would yield greater health, economic, and equity gains, but fiscal revenues would decline beyond certain tax share levels (72% for tobacco, 59% for alcohol, and 40% for SSBs).

Interpretation

Increasing excise taxes on tobacco, alcohol, and SSBs in China can simultaneously generate health benefits, macroeconomic gains, and additional fiscal revenues, as well as improve equity.

Funding

National Social Science Fund of China, the Taikang Yicai Public Health and Epidemic Control Fund, and Bill & Melinda Gates Foundation.

Translation

For the Chinese translation of the abstract see Supplementary Materials section.
中国面临着烟草、酒精和含糖饮料(SSB)消费带来的巨大负担,但这些产品的税收增长一直停滞不前。我们的目标是量化在中国增加这些税收的潜在影响。方法模拟了2026 - 2050年中国不同增税情景下的健康、宏观经济和财政后果。使用队列状态过渡模型,结合特定年龄、特定性别和特定收入的人口预测、消费模式、价格弹性和相对风险估计,估计了增加的寿命年数(YLGs)、避免的死亡和额外的财政收入。采用增强健康的宏观经济模型,通过增加劳动力供应和减少保健支出来计算宏观经济效益。进行敏感性分析以解释参数和结构的不确定性。结果:2026 ~ 2050年,在20%的价格上调幅度下,对烟草、酒精和SSBs征税将分别产生2058万(95%不确定区间为12.53 ~ 29.19)、902万(95%不确定区间为5.61 ~ 12.92)和367万(95%不确定区间为2.40 ~ 5.05)ylg,并分别避免0.86亿(0.53 ~ 3.23)、0.36亿(0.22 ~ 0.51)和0.13亿(0.09 ~ 0.19)的死亡。保健福利集中在低收入群体和男性中。这些健康改善将转化为宏观经济收益,分别相当于国内生产总值的0.043%(0.031 - 0.060)、0.034%(0.024 - 0.047)和0.0016%(0.0013 - 0.0019)。烟草的额外财政收入为4.53万亿日元(3.70 - 5.50万亿),酒精的额外财政收入为2.00万亿日元(1.75 - 2.29万亿),ssb的额外财政收入为2950亿日元(2.27 - 3.77万亿)。更高的税收将产生更大的健康、经济和股权收益,但财政收入将下降到一定的税收份额水平(烟草占72%,酒精占59%,ssb占40%)。在中国,增加烟草、酒精和SSBs的消费税可以同时产生健康效益、宏观经济收益和额外的财政收入,并改善公平。国家社科基金、泰康一财公共卫生与疫情控制基金、比尔及梅琳达·盖茨基金会。摘要的中文译文见补充资料部分。
{"title":"Health and economic effects of increased taxation on tobacco, alcohol, and sugar-sweetened beverages in China: a modelling study","authors":"Tiange Chen, Jinyi Zhu, Sian Tsuei, Yunyun Jiang, Yunting Zheng, Duo Xu, Hongqiao Fu","doi":"10.1016/s2468-2667(25)00256-7","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00256-7","url":null,"abstract":"<h3>Background</h3>China faces substantial burdens from tobacco, alcohol, and sugar-sweetened beverage (SSB) consumption, yet tax increases on these products have been stagnant. Existing evidence on the health, economic, and fiscal effects of such taxes in China is limited, which hinders tax reforms on tobacco and alcohol and implementation of SSB excise taxes. We aim to quantify the potential effects of increasing these taxes in China.<h3>Methods</h3>We modelled the health, macroeconomic, and fiscal consequences under different tax increase scenarios in China between 2026 and 2050. Years of life gained (YLGs), deaths averted, and additional fiscal revenue were estimated using a cohort state-transition model incorporating age-specific, sex-specific, and income-specific demographic projections, consumption patterns, price elasticities, and relative risk estimates. Macroeconomic benefits were calculated through enhanced labour supply and reduced health-care expenditures using a health-augmented macroeconomic model. Sensitivity analyses were conducted to account for parameter and structural uncertainties.<h3>Findings</h3>From 2026 to 2050, under 20% price increases through tax hikes, taxation of tobacco, alcohol, and SSBs would generate 20·58 million (95% uncertainty interval 12·53–29·19), 9·02 million (5·61–12·92), and 3·67 million (2·40–5·05) YLGs, respectively, and avert 0·86 million (0·53–1·23), 0·36 million (0·22–0·51), and 0·13 million (0·09–0·19) deaths, respectively. Health benefits were concentrated among lower-income groups and males. These health improvements would translate into macroeconomic gains equivalent to 0·043% (0·031–0·060), 0·034% (0·024–0·047), and 0·0016% (0·0013–0·0019) of total gross domestic product, respectively. Additional fiscal revenues would total ¥4·53 trillion (3·70–5·50) for tobacco, ¥2·00 trillion (1·75–2·29) for alcohol, and ¥295·5 billion (227·9–377·1) for SSBs. Higher taxes would yield greater health, economic, and equity gains, but fiscal revenues would decline beyond certain tax share levels (72% for tobacco, 59% for alcohol, and 40% for SSBs).<h3>Interpretation</h3>Increasing excise taxes on tobacco, alcohol, and SSBs in China can simultaneously generate health benefits, macroeconomic gains, and additional fiscal revenues, as well as improve equity.<h3>Funding</h3>National Social Science Fund of China, the Taikang Yicai Public Health and Epidemic Control Fund, and Bill &amp; Melinda Gates Foundation.<h3>Translation</h3>For the Chinese translation of the abstract see Supplementary Materials section.","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"22 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 2025 China report of the Lancet Countdown on health and climate change: empowering cities for synergistic action 《柳叶刀》健康与气候变化倒计时2025年中国报告:增强城市权能,采取协同行动
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-30 DOI: 10.1016/s2468-2667(25)00230-0
Wenjia Cai, Chi Zhang, Shihui Zhang, Yuqi Bai, Bin Chen, Jifei Chen, Liangliang Cheng, Weicheng Fan, Lianfang Feng, Dabo Guan, Congkai Hong, Yixin Hu, Junyi Hua, Cunrui Huang, Hong Huang, Jianbin Huang, Xiaomeng Huang, John S Ji, Qiaolei Jiang, Xiaopeng Jiang, Haidong Kan, Jun Kang, Gregor Kiesewetter, Bo Li, Guoao Li, Tiantian Li, Weiyi Liao, Borong Lin, Hualiang Lin, Huan Liu, Qiyong Liu, Xinghan Liu, Yanxiang Liu, Zehua Liu, Zhao Liu, Zhu Liu, Shuhan Lou, Bo Lu, Chenxi Lu, Wei Ma, Zhifu Mi, Yanqing Miao, Guangju Mo, Tim Repke, Chao Ren, Marina Romanello, Jianxiang Shen, Jing Su, Rui Su, Yuze Sun, Xu Tang, Maria Walawender, Can Wang, Hui Wang, Qing Wang, Qiong Wang, Yongyue Wang, Wangyu Wei, Sanmei Wen, Hui Xiong, Bing Xu, Xiu Yang, Yuren Yang, Fanghong Yao, Mingjun Yin, Le Yu, Zhaowu Yu, Jing Zhang, Rui Zhang, Shangchen Zhang, Shaohui Zhang, Zhenyu Zhang, Mengzhen Zhao, Qiang Zhao, Dashan Zheng, Hao Zhou, Jingbo Zhou, Yuye Zhou, Yong Luo, Peng Gong
According to the World Meteorological Organization (WMO), 2024 was the hottest year on record. China had unprecedented heat and heavy precipitation, with a national average temperature of 10·9°C, 1·01°C higher than the historical average (1991–2020), and annual precipitation of 697·7 mm, which is 9·0% higher than the average. As 2025 marks the 10th anniversary of the Paris Agreement and a key juncture for submitting new contributions, accelerating global climate action is imperative, especially in cities, which account for 58% of the world's population and 70% of total carbon emissions.
据世界气象组织(WMO)称,2024年是有记录以来最热的一年。中国出现了前所未有的高温强降水,全国平均气温为10.9℃,比历史平均(1991—2020年)高1.01℃,年降水量为697.7 mm,比历史平均(1991—2020年)高9.0%。2025年是《巴黎协定》签署10周年,也是提交新贡献的关键时刻,加快全球气候行动势在必行,尤其是在占世界人口58%、碳排放总量70%的城市。
{"title":"The 2025 China report of the Lancet Countdown on health and climate change: empowering cities for synergistic action","authors":"Wenjia Cai, Chi Zhang, Shihui Zhang, Yuqi Bai, Bin Chen, Jifei Chen, Liangliang Cheng, Weicheng Fan, Lianfang Feng, Dabo Guan, Congkai Hong, Yixin Hu, Junyi Hua, Cunrui Huang, Hong Huang, Jianbin Huang, Xiaomeng Huang, John S Ji, Qiaolei Jiang, Xiaopeng Jiang, Haidong Kan, Jun Kang, Gregor Kiesewetter, Bo Li, Guoao Li, Tiantian Li, Weiyi Liao, Borong Lin, Hualiang Lin, Huan Liu, Qiyong Liu, Xinghan Liu, Yanxiang Liu, Zehua Liu, Zhao Liu, Zhu Liu, Shuhan Lou, Bo Lu, Chenxi Lu, Wei Ma, Zhifu Mi, Yanqing Miao, Guangju Mo, Tim Repke, Chao Ren, Marina Romanello, Jianxiang Shen, Jing Su, Rui Su, Yuze Sun, Xu Tang, Maria Walawender, Can Wang, Hui Wang, Qing Wang, Qiong Wang, Yongyue Wang, Wangyu Wei, Sanmei Wen, Hui Xiong, Bing Xu, Xiu Yang, Yuren Yang, Fanghong Yao, Mingjun Yin, Le Yu, Zhaowu Yu, Jing Zhang, Rui Zhang, Shangchen Zhang, Shaohui Zhang, Zhenyu Zhang, Mengzhen Zhao, Qiang Zhao, Dashan Zheng, Hao Zhou, Jingbo Zhou, Yuye Zhou, Yong Luo, Peng Gong","doi":"10.1016/s2468-2667(25)00230-0","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00230-0","url":null,"abstract":"According to the World Meteorological Organization (WMO), 2024 was the hottest year on record. China had unprecedented heat and heavy precipitation, with a national average temperature of 10·9°C, 1·01°C higher than the historical average (1991–2020), and annual precipitation of 697·7 mm, which is 9·0% higher than the average. As 2025 marks the 10th anniversary of the Paris Agreement and a key juncture for submitting new contributions, accelerating global climate action is imperative, especially in cities, which account for 58% of the world's population and 70% of total carbon emissions.","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"113 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145404814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lancet Public Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1